Introduction
We previously compared bacampicillin, a prodrug ester of ampicillin that is hydrolysed to ampicillin after absorption, in a dose of 1 6 g (equivalent to I l 12 g ampicillin) with 3 -5 g ampicillin, both given with 1 g probenecid, in the treatment of uncomplicated gonorrhoea.' In that study we measured serum, urine, and salivary ampicillin concentrations two hours after administration of the antibiotics with probenecid, but were unable to detect any drug in the saliva with a microbiological assay sensitive to 0-01 mg/l. Combined data from four study groups showed treatment failure with 1 * 6 g bacampicillin in five of eight patients with pharyngeal gonorrhoea.2 Other workers had found ampicillin and amoxycillin given with probenecid as a single dose to be inadequate for the treatment of gonorrhoea at this site.3 DiCaprio et al, however, found ampicillin to be highly effective (96-99% cure rates for 77 patients with pharyngeal gonorrhoea) when using multiple doses (3 * 5 g ampicillin plus 1 g probenecid followed by ampicillin 500 mg every six hours for the succeeding two days).4
To find a more successful regimen for treating gonorrhoea of the genitalia, anorectum, and pharynx, we compared the efficacy of bacampicillin 4 8 g (equivalent to 3 * 36 g ampicillin) and 1 g probenecid with amoxycillin 3 g given with 1 g probenecid. Both these antibiotics are more completely absorbed and achieve better serum concentrations than ampicillin. The effect of probenecid given at the same time as opposed to half an hour before the antibiotics was not clear, particularly in relation to concentrations in saliva, so this was also studied.
Bacampicillin in a dose of 1 6 g gives no more gastrointestinal side effects than ampicillin in a dose of 3 5 g, but in one report gastrointestinal side effects were experienced by nearly half the patients receiving a dose of 2 4 Three patients entered into the study on the basis of known exposure to gonorrhoea were subsequently evaluated only for drug variables when their cultures were found to be negative for N gonorrhoeae. tSignificantly (t = 2-88; p<0 01) more amoxycillin in serum when probenecid administered before the antibiotic.
(Differences in urine concentration of amoxycillin and saliva, serum, and urine concentrations of bacampicillin not significant.) Table III Postgonococcal urethritis (PGU) occurred in 14 of 37 men, and there was no appreciable difference in incidence between those treated with amoxycillin (six of 18) and bacampicillin (eight of 19).
No abnormal laboratory findings could be associated with either antibiotic. No allergic rashes were noted. Table IV shows that 38 7% of the patients treated with bacampicillin experienced gastrointestinal side effects (six vomited (one also had five to six loose stools for one day) and six had nausea or one to two loose stools). There was a noticeable difference between patients who had food in their stomach during the previous one to three hours and those who took the medication on an empty stomach or with a small amount of food. The presence or absence of food in the stomach made no appreciable difference in those treated with amoxycillin.
No P-lactamase producing N gonorrhoeae were found in cultures that were positive on follow up. Significant difference between amoxycillin and bacampicillin (x2=9*6; p<0-01).
Significant effect of food in patients taking bacampicillin (X2 = 9-0; p<0O01).
Discussion
In our previous study we did not find ampicillin in the saliva two hours after administration of 1 6 g bacampicillin or 3 5 g ampicillin, each given simultaneously with 1 g probenecid.1 In this study a dose of 4*8 g bacampicillin given with 1 g probenecid gave mean saliva concentrations of more than 0'17 mg/l, the mean minimum inhibitory concentration (MIC) for N gonorrhoeae recorded for isolates in our previous study.'
Other workers found high (43-60%o) treatment failure rates for pharyngeal gonorrhoea with 3*5 g ampicillin, 1 6 g and 2@4 g bacampicillin, and 3 g amoxycillin (all given with 1 g probenecid).25 In 11 of our patients with pharyngeal gonorrhoea, eight of nine given 4 8 g bacampicillin and both patients given 3 g amoxycillin (all given with 1 g probenecid) had N gonorrhoeae eradicated from the pharynx, although the small number of patients treated and followed up obscures the relevance of these findings.
Some (table III) .
Earlier studies have suggested that bacampicillin may produce more gastrointestinal side effects than ampicillin.2 The presence of food already in the stomach (but not given simultaneously with the bacampicillin) was protective, but this is not convenient in most outpatient departments as the patients may have to wait an hour or so before the -administration of antibiotics. The role of the larger number of bacampicillin tablets is subject to conjecture. In this study amoxycillin had appreciably fewer gastrointestinal side effects than bacampicillin whether given on an empty or full stomach. We therefore believe further study is indicated using oral antibiotics that have the potential for eradicating pharyngeal N gonorrhoeae and N meningitidis. On the basis of this study, although bacampicillin is effective at the dose used, it is limited by the high incidence of gastrointestinal side effects. 
